BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35261637)

  • 1. Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells.
    Karlsson H; Fryknäs M; Senkowski W; Larsson R; Nygren P
    Oncol Lett; 2022 Apr; 23(4):123. PubMed ID: 35261637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer.
    Senkowski W; Zhang X; Olofsson MH; Isacson R; Höglund U; Gustafsson M; Nygren P; Linder S; Larsson R; Fryknäs M
    Mol Cancer Ther; 2015 Jun; 14(6):1504-16. PubMed ID: 25911689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.
    Buckel L; Savariar EN; Crisp JL; Jones KA; Hicks AM; Scanderbeg DJ; Nguyen QT; Sicklick JK; Lowy AM; Tsien RY; Advani SJ
    Cancer Res; 2015 Apr; 75(7):1376-1387. PubMed ID: 25681274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential radiosensitization in DNA mismatch repair-proficient and -deficient human colon cancer xenografts with 5-iodo-2-pyrimidinone-2'-deoxyribose.
    Seo Y; Yan T; Schupp JE; Colussi V; Taylor KL; Kinsella TJ
    Clin Cancer Res; 2004 Nov; 10(22):7520-8. PubMed ID: 15569982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
    Erlichman C; Vidgen D
    Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An agent-based model for drug-radiation interactions in the tumour microenvironment: Hypoxia-activated prodrug SN30000 in multicellular tumour spheroids.
    Mao X; McManaway S; Jaiswal JK; Patel PB; Wilson WR; Hicks KO; Bogle G
    PLoS Comput Biol; 2018 Oct; 14(10):e1006469. PubMed ID: 30356233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo.
    Tumber A; Collins LS; Petersen KD; Thougaard A; Christiansen SJ; Dejligbjerg M; Jensen PB; Sehested M; Ritchie JW
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):275-83. PubMed ID: 17124594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells.
    Ma H; Bi J; Liu T; Ke Y; Zhang S; Zhang T
    Oncol Rep; 2015 Mar; 33(3):1161-70. PubMed ID: 25572529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.
    Karlsson H; Fryknäs M; Larsson R; Nygren P
    Exp Cell Res; 2012 Aug; 318(13):1577-85. PubMed ID: 22487097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization by the histone deacetylase inhibitor PCI-24781.
    Banuelos CA; Banáth JP; MacPhail SH; Zhao J; Reitsema T; Olive PL
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6816-26. PubMed ID: 18006784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells.
    Dimas K; Tsimplouli C; Houchen C; Pantazis P; Sakellaridis N; Tsangaris GT; Anastasiadou E; Ramanujam RP
    Altern Ther Health Med; 2015; 21 Suppl 2():46-54. PubMed ID: 26308760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofarabine acts as radiosensitizer in vitro and in vivo by interfering with DNA damage response.
    Cariveau MJ; Stackhouse M; Cui XL; Tiwari K; Waud W; Secrist JA; Xu B
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):213-20. PubMed ID: 18037589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mithramycin A Radiosensitizes EWS:Fli1
    Lin MY; Damron TA; Oest ME; Horton JA
    Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1454-1471. PubMed ID: 33373655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization by the histone deacetylase inhibitor vorinostat under hypoxia and with capecitabine in experimental colorectal carcinoma.
    Saelen MG; Ree AH; Kristian A; Fleten KG; Furre T; Hektoen HH; Flatmark K
    Radiat Oncol; 2012 Sep; 7():165. PubMed ID: 23017053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours.
    Rofstad EK; Sutherland RM
    Br J Cancer; 1989 Jan; 59(1):28-35. PubMed ID: 2757922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation.
    Chattopadhyay N; Cai Z; Kwon YL; Lechtman E; Pignol JP; Reilly RM
    Breast Cancer Res Treat; 2013 Jan; 137(1):81-91. PubMed ID: 23160926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy.
    Khaitan D; Chandna S; Arya MB; Dwarakanath BS
    J Transl Med; 2006 Mar; 4():12. PubMed ID: 16509995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks.
    Wu L; Shao L; Li M; Zheng J; Wang J; Feng W; Chang J; Wang Y; Hauer-Jensen M; Zhou D
    Radiat Res; 2013 Feb; 179(2):160-70. PubMed ID: 23259762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
    Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery.
    Fiebig HH; Maier A; Burger AM
    Eur J Cancer; 2004 Apr; 40(6):802-20. PubMed ID: 15120036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.